SNAT1 level was associated with survival time and metastasis status, while silencing of the gene in human melanoma [74] and breast cancer cell lines [75] promoted senescence and diminished cell migration rate, thus indicating it as an important target in anticancer therapy. Here, SLC38A1 is linked to melanoma.